Patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation experienced ...

Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

A new, small cancer study may give hope to patients with solid tumors in the stomach, esophagus or rectum. The standard ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, will present preclinical data from its STX-003 program at the 2025 annual meetings of the ...

With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...